skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Motexafin gadolinium injection for the treatment of brain metastases in patients with non-small cell lung cancer

(2945) Views  (608) Full article downloads

Authors: Sayana R Thomas, Deepak Khuntia

Published Date May 2007 Volume 2007:2(1) Pages 79 - 87
DOI: http://dx.doi.org/10.2147/IJN.S

Sayana R Thomas, Deepak Khuntia

Department of Human Oncology, University of Wisconsin, Madison, WI, USA

Abstract: Despite recent advances in technology, targeting, and chemotherapy, brain metastasis from non-small cell lung cancer (NSCLC) remains a significant problem. The vast majority of patients with this diagnosis undergo whole brain radiation therapy (WBRT). However, outcomes are still quite poor with median survivals measured in only months. In an effort to enhance outcomes from external beam radiation treatments, radiosensitizers have been investigated. Motexafin gadolinium (MGd) (Xcytrin®, Sunnyvale, CA, USA) is a novel radiation sensitizer with a unique mechanism of action that may increase the therapeutic index of WBRT for patients with brain metastases, particularly in those with NSCLC histologies. Here we review the rationale for the use of this drug as well as its current and future role as a radiation enhancer in the management of NSCLC brain metastasis.

Keywords: radiation sensitizers, motexafin gadolinium, brain metastasis, redox modulators








Readers of this article also read:

High performance DNA nano-carriers of carbonate apatite: Multiple factors in regulation of particle synthesis and transfection efficiency
Nanomedicines in the treatment of anemia in renal disease: focus on CERA (Continuous Erythropoietin Receptor Activator)
Enhanced endothelial cell density on NiTi surfaces with sub-micron to nanometer roughness
Evidence-based decision-making within the context of globalization: A “Why–What–How” for leaders and managers of health care organizations
Radiolucency below the crown of mandibular horizontal incompletely impacted third molars and acute inflammation in men with diabetes
Berberine: metabolic and cardiovascular effects in preclinical and clinical trials
Amino acid management of Parkinson’s disease: a case study
Evaluation of in-vitro antibiotic susceptibility of different morphological forms of Borrelia burgdorferi
Long-term treatment of bipolar disorder with a radioelectric asymmetric conveyor
Comparison of two treatments for coxarthrosis: local hyperthermia versus radio electric asymmetrical brain stimulation